Gilead CEO expects remdesivir to effectively treat Covid strains found in UK, South Africa

by Raphael Stevens 11 January 2021, 13:38 169 Views

“I expect remdesivir with these variants will continue to make an impact on patients,” Gilead Sciences CEO Daniel O’Day told CNBC.

BioNTech says Covid vaccine is effective against key new strains; to publish more data in days

It Could Be a Great Year, if Your Business Survives Winter

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

Gilead CEO expects remdesivir to effectively treat Covid strains found in UK, South Africa

BioNTech says Covid vaccine is effective against key new strains; to publish more data in days

It Could Be a Great Year, if Your Business Survives Winter

ITALIAN LANGUAGE

ENGLISH LANGUAGE